Publications by authors named "Dimitra Stavroulaki"

Τhe synthesis of a series of novel hybrid block copolypeptides based on poly(ethylene oxide) (PEO), poly(l-histidine) (PHis) and poly(l-cysteine) (PCys) is presented. The synthesis of the terpolymers was achieved through a ring-opening polymerization (ROP) of the corresponding protected -carboxy anhydrides of --l-histidine and --butyl-l-cysteine, using an end-amine-functionalized poly(ethylene oxide) (PEO-NH) as macroinitiator, followed by the deprotection of the polypeptidic blocks. The topology of PCys was either the middle block, the end block or was randomly distributed along the PHis chain.

View Article and Find Full Text PDF

The synthesis of well-defined polypeptides exhibiting complex macromolecular architectures requires the use of monomers that can be orthogonally deprotected, containing primary amines that will be used as the initiator for the Ring Opening Polymerization (ROP) of N-carboxy anhydrides. The synthesis and characterization of the novel monomer -9-Fluorenylmethoxycarbonyl-l-Lysine -carboxy anhydride (-Fmoc-l-Lysine NCA), as well as the novel linear Poly(-Fmoc-l-Lys) homopolypeptide and Poly(l-Lysine)--[Poly(l-Lysine)-t-Poly(l-Histidine)] block-graft copolypeptide, are presented. The synthesis of the graft copolypeptide was conducted via ROP of the -Boc-l-Lysine NCA while using -hexylamine as the initiator, followed by the polymerization of -Fmoc-l-Lysine NCA.

View Article and Find Full Text PDF

Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year, representing one third of global mortality. As existing therapies still have limited success, due to the inability to control the biodistribution of the currently approved drugs, the quality of life of these patients is modest.

View Article and Find Full Text PDF

Over the last two decades, remarkable progress has been made to the discovery of novel drugs as well as their delivery systems for the treatment of cancer, the major challenge in medicine. Pharmaceutical scientists are trying to shift from traditional to novel drug delivery systems by applying nanotechnology and, in particular, polymeric carriers to medicine. In complex diseases, very sophisticated nanocarriers should be designed to encapsulate a significant quantity of drugs and bypass biological barriers with minimum cargo loss to effectively and directly deliver the encapsulated drug to the desired pathological site.

View Article and Find Full Text PDF

The highly diverse and sophisticated action of proteins results from their equally diverse primary structure, which along with the nature of interactions between the amino acids, defines the higher self-assembly of proteins. The interactions between amino acids can be very complicated, and their understanding is necessary in order to elucidate the protein structure-properties relationship. A series of well-defined hybrid-polypeptidic diblock copolymers of the type m-PEO-b-poly(His-co-Gly) and m-PEO-b-poly(His-co-Ala) was synthesized through the ring opening polymerization of the -carboxyanhydrides of the corresponding amino acids, with a molar ratio of the hydrophobic peptide to histidine at 10%, 20% and 40%.

View Article and Find Full Text PDF
Article Synopsis
  • The development of multifunctional polymeric materials aims to encapsulate pharmaceutical compounds to create nanoconstructs, which control drug distribution and minimize side effects.
  • Micelles, made from amphiphilic polymers in water, trap hydrophobic drugs for delivery via the bloodstream.
  • The article reviews synthetic methods for polypeptide-based polymeric micelles, highlighting their potential in cancer therapy, and focuses on studies conducted from 2000 to 2017.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Dimitra Stavroulaki"

  • - Dimitra Stavroulaki's recent research primarily focuses on the synthesis and characterization of hybrid polypeptides and the development of advanced drug delivery systems, particularly for cancer treatment and cardiovascular diseases.
  • - Significant findings include the creation of novel copolypeptides, such as poly(L-histidine) and poly(L-cysteine), with tailored properties that enhance drug encapsulation and release, demonstrating the potential of these materials in controlling biodistribution.
  • - The studies emphasize the importance of nanotechnology and polymeric carriers in overcoming biological barriers, advocating for the design of multifunctional systems that ensure effective delivery of therapeutics while minimizing side effects.